Skip to Content

Cephalexin Oral Suspension

Last Updated: November 4, 2014
Status: Resolved

Products Affected - Description

Cephalexin oral suspension, Orchid/Karalax
125 mg/5 mL, 100 mL (NDC 42043-0142-38) - discontinued
125 mg/5 mL, 200 mL (NDC 42043-0142-58) - discontinued
250 mg/5 mL, 100 mL (NDC 42043-0143-38) - discontinued
250 mg/5 mL, 200 mL (NDC 42043-0143-58) - discontinued

 
Cephalexin oral suspension, Ranbaxy
125 mg/5 mL, 100 mL (NDC 63304-0958-01)
125 mg/5 mL, 200 mL (NDC 63304-0958-02)
250 mg/5 mL, 100 mL (NDC 63304-0959-01)
250 mg/5 mL, 200 mL (NDC 63304-0959-02)

Reason for the Shortage

  • Orchid/Karalax discontinued all cephalexin oral suspension products in the 3rd Quarter of 2013.
  • Ranbaxy has an import ban on their cephalexin oral suspension products.
  • Carlsbad Technology, Inc. discontinued all cephalexin oral suspension products in late-2012 due manufacturing cost and shortage or raw materials.
  • Teva could not provide a reason for the shortage.

Available Products

Cephalexin oral suspension, Lupin
125 mg/5 mL, 100 mL (NDC 68180-0123-01)
125 mg/5 mL, 200 mL (NDC 68180-0123-02)
250 mg/5 mL, 100 mL (NDC 68180-0124-01)
250 mg/5 mL, 200 mL (NDC 68180-0124-02)

Cephalexin oral suspension, Teva
125 mg/5 mL, 100 mL (NDC 00093-4175-73)
125 mg/5 mL, 200 mL (NDC 00093-4175-74)
250 mg/5 mL, 100 mL (NDC 00093-4177-73)
250 mg/5 mL, 200 mL (NDC 00093-4177-74)

Estimated Resupply Dates

  • Ranbaxy has all cephalexin oral suspension products on import ban and the company cannot estimate when product will return.
  • All other marketed products are available.

Related Shortages

Updated

November 4, 2014; September 15, 2014; July 9, 2014; May 14, 2014; March 12, 2014; January 8, 2014; October 21, 2013; September 25, 2013; August 27, 2013; July 19, 2013 University of Utah, Drug Information Service. Copyright 2014, Drug Information Service, University of Utah, Salt Lake City, UT.

Hide